We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Failure of yttrium-90 (<sub>90</sub>Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin<sup>®</sup>) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas.
- Authors
Şerefhanoğlu, Songül; Koca, Ebru; Goker, Hakan; Haznedaroğlu, İbrahim Celalettin; Çetiner, Deniz; Sayınalp, Nilgün; Büyükaşık, Yahya; Özcebe, Osman İlhami
- Abstract
A letter to the editor is presented which solicits clarification on the failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin®) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas.
- Subjects
LETTERS to the editor; RADIOIMMUNOTHERAPY
- Publication
Turkish Journal of Hematology, 2008, Vol 25, Issue 4, p207
- ISSN
1300-7777
- Publication type
Letter